Publication:
Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma

dc.contributor.authorCastaneda, Carlos
dc.contributor.authorCastillo, Miluska
dc.contributor.authorTorres-Cabala, C
dc.contributor.authorBernabe, LA
dc.contributor.authorCasavilca, S
dc.contributor.authorVillegas, V
dc.contributor.authorSanchez, J
dc.contributor.authorde la Cruz, M
dc.contributor.authorDunstan, J
dc.contributor.authorCotrina, JM
dc.contributor.authorGomez, HL
dc.contributor.authorChavez, C
dc.contributor.authorLanda-Baella, MP
dc.contributor.authorTello, K
dc.contributor.authorFelix, BF
dc.contributor.authorAbugattas, J
dc.date.accessioned2024-04-05T15:45:35Z
dc.date.available2024-04-05T15:45:35Z
dc.date.issued2013
dc.description.abstractPurpose: This study aims to evaluate the association between composition of tumor-infiltrating lymphocytes (TIL) and expression of p16 in acral lentiginous melanoma (ALM), and their impact on prognosis.
dc.formatapplication/pdf
dc.identifier.doi10.1007/s12094-019-02033-x
dc.identifier.journalClinical and Translational Oncology
dc.identifier.urihttps://hdl.handle.net/20.500.14703/65
dc.language.isoeng
dc.publisherSpringer-Verlag Italia Srl
dc.publisher.countryIT
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDspace
dc.subjectOpen access
dc.subjectRepositorio digital
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.21
dc.titleRelationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Files